Caspase 3 induction was observed after treatment with complex 2, which is indicative that breast cancer cells are undergoing apoptosis, as reported in another study that used venetoclax on the same breast cancer cell line, MDA-MB-231 [57]. This evidence concerns the gene CASP3 and breast carcinoma.